NEOLEUKIN THERAPEUTICS, INC. – Trademark Portfolio
Entity Type: 03
NEOLEUKIN THERAPEUTICS, INC. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include NEOLEUKIN. The owner is based in SEATTLE, WA.
SEATTLE, WA 98102
Showing of trademarks Trademarks
Trademark Classifications
NEOLEUKIN THERAPEUTICS, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does NEOLEUKIN THERAPEUTICS, INC. have?
NEOLEUKIN THERAPEUTICS, INC. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does NEOLEUKIN THERAPEUTICS, INC. file in?
NEOLEUKIN THERAPEUTICS, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.
What are NEOLEUKIN THERAPEUTICS, INC.'s most well-known trademarks?
NEOLEUKIN THERAPEUTICS, INC.'s registered trademark portfolio includes well-known marks such as NEOLEUKIN. These are among 1 currently registered trademark in the portfolio.
What is NEOLEUKIN THERAPEUTICS, INC.'s trademark registration success rate?
NEOLEUKIN THERAPEUTICS, INC. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.